PULMONARY HYPERTENSION
Clinical trials for PULMONARY HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PULMONARY HYPERTENSION trials appear
Sign up with your email to follow new studies for PULMONARY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to help lungs and heart work better during exercise
Disease control TerminatedThis phase 3 trial tests whether ralinepag, an oral medication, can improve exercise capacity in people with pulmonary arterial hypertension (PAH) who have recently started PAH therapy. Participants take ralinepag or a placebo for 28 weeks, and their peak oxygen consumption durin…
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Inhaled treprostinil safety trial for PH-COPD ends early
Disease control TerminatedThis study looked at the long-term safety of an inhaled drug called treprostinil in people who have both pulmonary hypertension (high blood pressure in the lungs) and COPD. It included 41 adults who had already completed a previous study. The trial was terminated early, and the m…
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Heart failure drug trial ends early – only 4 patients enrolled
Disease control TerminatedThis was a very early (Phase 1) study testing a drug called HS135 in obese patients who have both pulmonary hypertension and a type of heart failure called HFpEF. The trial was terminated after enrolling only 4 people, so we have no useful information on whether HS135 is safe or …
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE1 • Sponsor: 35Pharma Inc • Aim: Disease control
Last updated Jun 26, 2026 14:09 UTC